Product Information
MOEXIPRIL HCL 7.5 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.8940 per EA under NDC 68462020901. Its NADAC has been published 643 times since Nov 28, 2013.
FDA first approved this application on Mar 30, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462020901
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MOEXIPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090416FDA Approved
3/30/2010
TE Code
AB
On Market Since
12/31/2010
Pharmacological Classes
Price Statistics
The NADAC for MOEXIPRIL HCL 7.5 MG TABLET has been published 643 times since Nov 28, 2013, and over the history we have for it it has risen 199.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8940 per EA |
|---|---|
| All-time high | $0.9671 (Apr 15, 2026) |
| All-time low | $0.2985 (Nov 28, 2013) |
| 52-week high | $0.9671 |
| 52-week low | $0.8877 |
| Median price | $0.7553 |
| Average price | $0.7729 |
| Largest weekly change | +76.0% (Dec 18, 2013) |
| Weeks tracked | 643 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MOEXIPRIL HCL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MOEXIPRIL HCL 7.5 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.8940 per EA (NDC 68462020901), effective Aug 19, 2026.
How has the price of MOEXIPRIL HCL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MOEXIPRIL HCL 7.5 MG TABLET has risen 199.5%. It has been tracked across 643 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MOEXIPRIL HCL 7.5 MG TABLET?
Since Nov 28, 2013, the NADAC for MOEXIPRIL HCL 7.5 MG TABLET has ranged from a low of $0.2985 (Nov 28, 2013) to a high of $0.9671 (Apr 15, 2026), with a median of $0.7553 per EA.
Are there cheaper alternatives to MOEXIPRIL HCL 7.5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MOEXIPRIL HCL 7.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MOEXIPRIL HCL 7.5 MG TABLET?
MOEXIPRIL HCL 7.5 MG TABLET (NDC 68462020901) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.